High Throughput Hardware/Software Co-Design Approach for SHA-256 Hashing Cryptographic Module In IPSec/IPv6

Nowadays, more than ever, security is considered to be critical issue for all electronic transactions. This is the reason why security services like those described in IPSec are mandatory to IPV6 which will be adopted as the new IP standard the next years. In fact E.U. has set the target of moving to IPv6 for about 25% of European e-infrastructures in 2010. However the need for security services in every data packet that is transmitted via IPv6, illustrates the need for designing security products able to achieve higher throughput rates for the incorporated security schemes. In this paper a top-down methodology is presented which manages to increase throughput of SHA-256 hash function hardware design. The higher degree of throughput with limited area penalty and cost is achieved through appropriate Software/Hardware partitioning and design

EUSOMA quality indicators for non-metastatic breast cancer: An update.

Quality care in breast cancer is higher if patients are treated in a Breast Center with a dedicated and specialized multidisciplinary team. Quality control is an essential activity to ensure quality care, which has to be based on the monitoring of specific quality indicators. Eusoma has proceeded with the up-dating of the 2017 Quality indicators for non-metastatic breast cancer based on the new diagnostic, locoregional and systemic treatment modalities. To proceed with the updating, EUSOMA setup a multidisciplinary working group of BC experts and patients' representatives. It is a comprehensive set of QIs for early breast cancer care, which are classified as mandatory, recommended, or observational. For the first time patient reported outcomes (PROMs) have been included. As used in the 2017 EUSOMA QIs, evidence levels were based on the short version of the US Agency for Healthcare Research and Quality. This is a set of quality indicators representative for the different steps of the patient pathway in non-metastatic setting, which allow Breast Centres to monitor their performance with referring standards, i.e minimum standard and target. Monitoring these Quality Indicators, within the Eusoma datacentre will allow to have a state of the art picture at European Breast Centres level and the development of challenging research projects